Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia

BACKGROUND: The question of which parameters may be informative on venetoclax outcome in chronic lymphocytic leukemia (CLL) is still unclear. Furthermore, the choice to treat with venetoclax can be challenging in patients with baseline characteristics or comorbidities that may potentially favor some...

Descripción completa

Detalles Bibliográficos
Autores principales: Frustaci, Anna Maria, Del Poeta, Giovanni, Visentin, Andrea, Sportoletti, Paolo, Fresa, Alberto, Vitale, Candida, Murru, Roberta, Chiarenza, Annalisa, Sanna, Alessandro, Mauro, Francesca Romana, Reda, Gianluigi, Gentile, Massimo, Varettoni, Marzia, Baratè, Claudia, Borella, Chiara, Greco, Antonino, Deodato, Marina, Zamprogna, Giulia, Laureana, Roberta, Cipiciani, Alessandra, Galitzia, Andrea, Curto Pelle, Angelo, Morelli, Francesca, Malvisi, Lucio, Coscia, Marta, Laurenti, Luca, Trentin, Livio, Montillo, Marco, Cairoli, Roberto, Tedeschi, Alessandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554118/
https://www.ncbi.nlm.nih.gov/pubmed/36246422
http://dx.doi.org/10.1177/20406207221127550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554118/
https://www.ncbi.nlm.nih.gov/pubmed/36246422
http://dx.doi.org/10.1177/20406207221127550

Ejemplares similares